Gemcitabine, oxaliplatin and 5-FU in advanced bile duct and gallbladder carcinoma: two parallel, multicentre phase-II trials

BACKGROUND: Gemcitabine, oxaliplatin and 5-fluorouracil (5-FU) are active in biliary tract cancer and have a potentially synergistic mode of action and non-overlapping toxicity. The objective of these trials was to determine response, survival and toxicity separately in patients with bile duct cance...

Descripción completa

Detalles Bibliográficos
Autores principales: Wagner, A D, Buechner-Steudel, P, Moehler, M, Schmalenberg, H, Behrens, R, Fahlke, J, Wein, A, Behl, S, Kuss, O, Kleber, G, Fleig, W E
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2009
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2788250/
https://www.ncbi.nlm.nih.gov/pubmed/19904267
http://dx.doi.org/10.1038/sj.bjc.6605377

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2788250/
https://www.ncbi.nlm.nih.gov/pubmed/19904267
http://dx.doi.org/10.1038/sj.bjc.6605377

Ejemplares similares